Amendment Statement of Principles concerning myeloma No. 72 of 2014

Administered by Department of Veterans' Affairs

Legislation au F2014L00936 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 72 OF 2014

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(10) of the Veterans’ Entitlements Act 1986 (the VEA) Amendment Statement of Principles Instrument No. 72 of 2014 concerning myeloma.
  2. This instrument amends Statement of Principles Instrument No. 69 of 2012 concerning myeloma by:
  • inserting new factor 6(da) concerning 'exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD)'; and
  • specifying the date of effect of this amendment.

3.             The changes are made at the direction of the Specialist Medical Review Council (the SMRC) in accordance with its Declaration No. 23 dated 12 May 2014.  The SMRC Declaration appeared in the Government Notices Gazette of 13 May 2014.

4.             In accordance with subsection 196B(13) of the VEA, the changes as made by Instrument No. 72 of 2014, take effect from 13 May 2014.

5.             As these changes provide additional means by which myeloma can be related to relevant service the earlier date of effect does not affect the rights of claimants so as to disadvantage them nor would it impose additional liabilities on them.

6.             No consultation was undertaken by the Authority prior to determining this Instrument, as the changes are made at the direction of the SMRC in accordance with section 196W of the VEA. The SMRC undertook public notification and consultation as part of its consideration of the matter, inviting eligible persons or organisations to make submissions. The SMRC decision, and directions to the Authority, were contained in a Declaration published in the Government Notices Gazette of 13 May 2014.

7.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 72 of 2014

Kind of Injury, Disease or Death: Myeloma

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(10) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have myeloma;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes a new factor which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting myeloma with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 69 of 2012; and
  • reflects the Specialist Medical Review Council's review of the available sound medical-scientific evidence concerning myeloma considered by the Repatriation Medical Authority when that earlier instrument was determined.

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

[1] In General Comment No. RH (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 72 of 2014 is an amendment to the Statement of Principles Instrument No. 69 of 2012 concerning myeloma, introduced to address the problem of expanding the criteria for linking myeloma to military service by including a new factor related to exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD). This instrument was enacted in accordance with the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, under the direction of the Specialist Medical Review Council (SMRC). The policy objective of this amendment is to enhance the medico-scientific quality of outcomes by providing clearer criteria for assessing claims related to myeloma, thereby facilitating the assessment and determination of social security benefits and ensuring the rights of veterans and their dependents are protected and promoted. The changes are designed to ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, ultimately supporting the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health.

Scope and Application

The Repatriation Medical Authority Instrument No. 72 of 2014, as outlined in the explanatory notes for tabling, concerns the amendment of Statement of Principles Instrument No. 69 of 2012 regarding myeloma under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This instrument is specifically tailored to address claims related to myeloma by inserting a new factor concerning exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) and specifying the effective date of these amendments. This legislative instrument applies to eligible persons who have been diagnosed with myeloma and are seeking compensation or medical treatment related to their service. The changes are directed by the Specialist Medical Review Council and are applicable from 13 May 2014, a date that ensures the rights of existing claimants are not adversely affected. While the Repatriation Medical Authority itself did not engage in consultation for this instrument, the Specialist Medical Review Council undertook public notification and consultation as part of its review process. The instrument is designed to enhance the quality of medico-scientific outcomes under the VEA and MRCA and is compatible with human rights, promoting the rights of veterans, current and former Defence Force members, and their dependents.

Key Provisions

The main provisions of this legislation, namely Instrument No. 72 of 2014, concern the amendment of the Statement of Principles Instrument No. 69 of 2012 regarding myeloma. This amendment is made under subsection 196B(10) of the Veterans' Entitlements Act 1986 (VEA) (paragraph 2). The changes include the insertion of a new factor 6(da), which pertains to exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) (paragraph 3). These amendments aim to facilitate claims by specifying circumstances under which medical treatment and compensation can be extended to eligible persons who have myeloma (paragraph 2). Furthermore, the amendments reflect the Specialist Medical Review Council’s (SMRC) review of available medical-scientific evidence concerning myeloma (paragraph 3). The obligations and requirements imposed by this Act primarily focus on the Repatriation Medical Authority and the claimants. The Authority is tasked with implementing the changes directed by the SMRC and ensuring that the new Statement of Principles is used in assessing claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA) (paragraph 2). Claimants, on the other hand, must ensure that they meet the qualifying conditions specified by the amended Statement of Principles when seeking medical treatment and compensation for myeloma (paragraph 2). The Act also facilitates the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal (paragraph 2). There are no specific offences, penalties, or consequences mentioned in the document for breach of the provisions of this Act. However, any failure to comply with the specified conditions for claiming benefits could potentially result in the denial of claims for medical treatment and compensation. The Act ensures that these changes do not disadvantage claimants or impose additional liabilities on them (paragraph 5). Moreover, the compatibility of the Legislative Instrument with human rights is affirmed, ensuring that the rights of veterans, current and former Defence Force members, and their dependents are upheld (paragraph 4).

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Rights & Protections

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.